Ablative Solutions: Funding, Investors & Team (Sep 2026)
Ablative Solutions is a clinical gadget firm that offers an option in contrast to careful renal denervation for treating hypertension. Its innovation includes endovascular catheters to give a solid, sturdy, practical, and safe option in contrast to careful renal denervation for the treatment of hypertension and different illnesses brought about by an overactive thoughtful sensory system. The organization was established in 2011 by Tim Fischell, MD, FACC, and David Fischell, Ph.D., to address this huge neglected clinical need.
Ablative Solutions has raised $91.4M across 1 funding round on record, the most recent a Series D of $91.4M announced in Jun 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ablative Solutions Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Ablative Solutions Funding Rounds
Ablative Solutions Founders and Leadership Team
No contact details are on record for this team yet.
Ablative Solutions Funding Compared to Other Biotechnology Startups
Ablative Solutions' latest round of $91.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ablative Solutions in Biotechnology and San Jose
Companies Similar to Ablative Solutions
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Ablative Solutions Funding FAQs
What does Ablative Solutions do?
Ablative Solutions is a clinical gadget firm that offers an option in contrast to careful renal denervation for treating hypertension. Its innovation includes endovascular catheters to give a solid, sturdy, practical, and safe option in contrast to careful renal denervation for the treatment of hypertension and different illnesses brought about by an overactive thoughtful sensory system. The organization was established in 2011 by Tim Fischell, MD, FACC, and David Fischell, Ph.D., to address this huge neglected clinical need.
How much funding has Ablative Solutions raised?
Ablative Solutions has raised $91.4M across 1 round on record. The most recent is a Series D of $91.4M announced in Jun 2022.
When did Ablative Solutions last raise funding?
Ablative Solutions' most recent funding round on record is a Series D of $91.4M, announced in Jun 2022.
Who founded Ablative Solutions?
FundedIQ lists David Fischell (Founder) at Ablative Solutions.
Where is Ablative Solutions headquartered?
Ablative Solutions is based in San Jose, California, United States.
How many employees does Ablative Solutions have?
Ablative Solutions is in the 11-50 employee band.
How does Ablative Solutions' funding compare to other Biotechnology startups?
Ablative Solutions' latest round of $91.4M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Ablative Solutions Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ablative Solutions is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.